Polymer modified asphalts have recently been the focus of much attention in the U.S. due to claims that polymer additives will lengthen the life of an asphalt pavement. Much of the published research on this topic has been concentrated on the effects of polymer modifiers on binder and mixture properties. The goal of this testing is to predict from laboratory testing the actual field performance of an asphalt concrete. Over the years, specifications have been developed for conventional asphalts that allow pavement performance to be predicted from certain binder tests. These conventional binder tests do not fully address the special characteristics of polymer modified asphalt binders and need revision to be an effective tool in predicting pavement service life. This paper presents the findings of a two-part laboratory research program intended to relate binder and mixture properties of polymer modified asphalts. The preliminary testing involved five asphalt binder types and a variety of binder and mixture tests. Promising test procedures were further investigated in the final testing program where ten asphalt binders were examined. Simple linear regression was used to determine the strength of a relationship between pairs of binder properties and mixture properties. The preliminary testing showed penetration, toughness and tenacity, and force ductility to have the most promise in predicting mixture performance. The final testing contained enough data to be analyzed with both simple linear regression and multiple regression. Penetration, toughness and tenacity, force ductility again were the test procedures that had binder properties that correlated well with mixture properties.

Following the five-year study performed to investigate the behavior of binders and asphalt mixtures containing polymer modifiers, it was determined that an insufficient amount of time had elapsed to allow any determinations to be made based upon the special field test sections. The study reported herein was to extend that initial time and to study in depth those special test sections, using visual observations coupled with resulting tests performed on samples extracted from the sections and comparisons with the original data developed in the original research. The research includes laboratory testing of field samples, determining the aging effect on the control and modified binders and corresponding effect on the mixtures, and visual evaluations. Retained samples of the original asphalts were also evaluated for potential performance as determined by the performance-based asphalt binder specification developed by the Strategic Highway Research Program. Four hot mix pavement field projects were constructed in the Tyler, Lufkin, San Antonio, and Childress Districts (10, 11, 15, and 25, respectively), and two seal coat projects were placed in the Odessa and Bryan Districts (6 and 17).

"ASTM Publication Code Number (PCN) 04-011080-08. - "Sponsored by ASTM Committee D-4 on Road and Paving Materials."-- Foreword. - Includes bibliographical references and indexes. - Electronic reproduction; W. Conshohocken, Pa; ASTM International; 2011; Mode of access: World Wide Web; System requirements: Web browser; Access may be restricted to users at subscribing institutions.

The global response to COVID-19 has demonstrated the importance of vigilance and preparedness for infectious diseases, particularly influenza. There is a need for more effective influenza vaccines and modern manufacturing technologies that are adaptable and scalable to meet demand during a pandemic. The rapid development of COVID-19 vaccines has demonstrated what is possible with extensive data sharing, researchers who have the necessary resources and novel technologies to conduct and apply their research, rolling review by regulators, and public-private partnerships. As demonstrated throughout the response to COVID-19, the process of research and development of novel vaccines can be significantly optimized when stakeholders are provided with the resources and technologies needed to support their response. Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response focuses on how to leverage the knowledge gained from the COVID-19 pandemic to optimize vaccine research and development (R&D) to support the prevention and control of seasonal and pandemic influenza. The committee's findings address four dimensions of vaccine R&D: (1) basic and translational science, (2) clinical science, (3) manufacturing science, and (4) regulatory science.